New Tuberculosis Tests Used in Health Facilities in Indonesia
Tests whether new non-sputum tests help find more tuberculosis cases in Indonesia.
Plain-language title generated from the registry record
Registry title: Evaluation and Demonstration of New Tuberculosis Diagnostics for Indonesia
Key facts
- Where
- Bandung, IndonesiaSee the site
Where in Indonesia
- Bandung District Health OfficeBandung, IndonesiaTaking people
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- Universitas Padjadjaran
- Trial code
- NCT07293455
- Record updated
- 25 September 2026
- Original description
The goal of this cluster-randomised controlled trial (CRCT) is to learn whether the use of new non-sputum-based diagnostic tests and other intervention components for tuberculosis (TB) diagnosis in healthcare facilities (HCF) can increase TB notifications. The main questions it aims to answer are: (1) Does the diagnostic intervention package raise TB notifications by HCF?; (2) Does the diagnostic intervention package raise the proportion of patients with TB who are diagnosed with microbiological tests, lower the time needed for TB diagnosis, lower the number of visits to HCF before TB diagnosis, raise the use of TB tests by healthcare providers, and lower the costs for TB diagnosis?Read full original descriptionShow less
Evaluation and Demonstration of New Tuberculosis Diagnostics for Indonesia; Work Package 3: Cluster Randomised Controlled Trial of A Diagnostic Package to Increase the Number of Tuberculosis Cases Notified
The goal of this cluster-randomised controlled trial (CRCT) is to learn whether the use of new non-sputum-based diagnostic tests and other intervention components for tuberculosis (TB) diagnosis in healthcare facilities (HCF) can increase TB notifications. The main questions it aims to answer are: (1) Does the diagnostic intervention package raise TB notifications by HCF?; (2) Does the diagnostic intervention package raise the proportion of patients with TB who are diagnosed with microbiological tests, lower the time needed for TB diagnosis, lower the number of visits to HCF before TB diagnosis, raise the use of TB tests by healthcare providers, and lower the costs for TB diagnosis?
Researchers will compare the diagnostic intervention package provided to HCFs and the community in the intervention arm with the standard of care in the control arm to assess the intervention's effect. Healthcare providers will be trained to provide diagnostic interventions to patients visiting their HCFs and to community residents in the areas surrounding HCFs.
Inclusion: Aged between >28 days and 14 years old with the following symptoms:; Cough ≥2 weeks; Acute malnutrition; Weight loss or weight faltering during the past 3 months among those who had contact history with patients with TB in the past 12 months; Aged ≥15 years old who had a cough for ≥2 weeks or bloody cough, with or without the following symptoms:; Cough with/without sputum; Fever; Weight loss; Night sweat; Fatigue; Chest pain/discomfort; Breathlessness; Loss of appetite; Shivering.
Exclusion: Have started TB treatment or TB prophylaxis therapy.